A randomised trial evaluating pain and bleeding after a first trimester miscarriage treated surgically or medically

Area of Science:

• Reproductive Medicine
• Clinical Trials

Background:

• Miscarriage is a common pregnancy complication.
• Management options include surgical and medical treatments.
• Comparative effectiveness data is crucial for clinical decision-making.

Purpose of the Study:

• To compare the outcomes of surgical versus medical management of miscarriage.
• To evaluate differences in pain, bleeding, hospital attendances, and hemoglobin levels.

Main Methods:

• A randomized controlled trial was conducted.
• Participants were assigned to either surgical or medical miscarriage treatment.
• Key outcome measures included pain, vaginal bleeding, hospital visits, and hemoglobin changes.

Main Results:

• Surgical treatment resulted in significantly less pain (P < 0.03) and vaginal bleeding (duration and severity, P = 0.001).
• Fewer daily hospital attendances were observed with surgical management (2.5 vs. 3, P = 0.04).
• A greater drop in hemoglobin concentration was noted after surgical treatment (difference, 1 g/dl; CI95% = 0.3-1.6).

Conclusions:

• Surgical management of miscarriage appears superior in reducing pain and bleeding.
• Medical professionals should consider the trade-off between symptom control and potential hemoglobin decrease.
• Further research may explore strategies to mitigate hemoglobin drop in surgical miscarriage treatment.